Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.36 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2739902 | 0.88 | CHRM1 (0.33) | CHRM1MAPTALDH1A1CA12GMNN | |
| SCHEMBL12641415 | 0.84 | ALDH1A1 (0.44) | CHRM1MAPTALDH1A1CA12GMNN | |
| SCHEMBL18222843 | 0.84 | CHRM1 (0.34) | CHRM1MAPTALDH1A1CA12GMNN | |
| SCHEMBL14491530 | 0.81 | MAPT (0.34) | MAPTALDH1A1CA12GMNNCA1 | |
| SCHEMBL23872913 | 0.80 | HMGCR (0.34) | MAPTALDH1A1CA12GMNNCA1 | |
| SCHEMBL16744315 | 0.80 | CHRM1 (0.35) | CHRM1MAPTALDH1A1CA12GMNN | |
| SCHEMBL20962040 | 0.80 | MAPT (0.32) | MAPTALDH1A1CA12GMNNCA1 | |
| SCHEMBL18403070 | 0.80 | CHRM1 (0.33) | CHRM1 | |
| SCHEMBL21278894 | 0.80 | TSHR (0.33) | MAPTALDH1A1CA12GMNNCA1 | |
| SCHEMBL11982735 | 0.80 | TSHR (0.33) | MAPTALDH1A1CA12GMNNCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10928727-B2 | Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, mask blank including actinic ray-sensitive or radiation-sensitive film, pattern forming method, and method for manufacturing | FUJIFILM CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| EP-3098216-B1 | NOVEL ESTER COMPOUND, AND COSMETIC COMPONENT AND COSMETIC PRODUCT EACH CONTAINING SAME | KOKYU ALCOHOL KOGYO CO LTD (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-10010493-B2 | Ester compound, and cosmetic component and cosmetic product each containing same | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20180120701-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, MASK BLANK INCLUDING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| EP-3098216-A1 | NOVEL ESTER COMPOUND, AND COSMETIC COMPONENT AND COSMETIC PRODUCT EACH CONTAINING SAME | Kokyu Alcohol Kogyo Co., Ltd. (JP) | 2016-11-30 | — | — | EP | disclosed |
| US-20160331661-A1 | NOVEL ESTER COMPOUND, AND COSMETIC COMPONENT AND COSMETIC PRODUCT EACH CONTAINING SAME | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160331661-A1 | NOVEL ESTER COMPOUND, AND COSMETIC COMPONENT AND COSMETIC PRODUCT EACH CONTAINING SAME | DECR2, DECR1, CYP51A1 | CHRM1 3199/4885MAPT 4201/4885ALDH1A1 235/4885 |
| US-10010493-B2 | Ester compound, and cosmetic component and cosmetic product each containing same | DECR2, DECR1, CYP51A1 | CHRM1 3111/4885MAPT 4054/4885ALDH1A1 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.